GHDx
Published on GHDx (https://ghdx.healthdata.org)


In May 2020, 4.5% of the population of metropolitan France had developed antibodies against SARS-CoV-2

General Info

Provider 
Directorate for Research, Studies, Evaluation, and Statistics (France)
Tabulations only
Geography 
France (FRA)
Grand Est, Guadeloupe, Hauts-de-France, Martinique, Normandie, Provence-Alpes-Côte d'Azur, Réunion, Île-de-France
Coverage type 
Subnational
Time period covered 
May, 2020 - August, 2020
Data type
Survey: Longitudinal
Keywords 
COVID-19, Medical tests, Prevalence

Citation

Contributors 
Directorate for Research, Studies, Evaluation, and Statistics (France)
French Institute of Health and Medical Research (INSERM)
National Institute of Statistics and Economic Studies (INSEE) (France)
Authors 
Warszawski J, Bajos N, Meyer L, de Lamballerie X, Seng R, Beaumont A, Slama R, Hisbergues M, Rahib D, Lydie N, Legendre B, Barlet M, Rey S, Raynaud P, Leduc A, Costemalle V, Beck F, Legleye S, Castell L, Givord P, Favre-Martinoz C, Paliod N, Sihol J, Sillard P
Journal 
Études Résult
Pages 
1-6
Publication year 
2020
Suggested citation 

Warszawski J, Bajos N, Meyer L, de Lamballerie X, Seng R, Beaumont A, Slama R, Hisbergues M, Rahib D, Lydie N, Legendre B, Barlet M, Rey S, Raynaud P, Leduc A, Costemalle V, Beck F, Legleye S, Castell L, Givord P, Favre-Martinoz C, Paliod N, Sihol J, Sillard P. In May 2020, 4.5% of the population of metropolitan France had developed antibodies against SARS-CoV-2. Études et Résultats. 2020; (1167): 1-6.


Source URL:https://ghdx.healthdata.org/record/may-2020-45-population-metropolitan-france-had-developed-antibodies-against-sars-cov-2